Clinical trials are critical to many medical advances; however, recruiting patients remains a persistent obstacle. Automated clinical trial matching could expedite recruitment across all trial phases. We detail our initial efforts towards automating the matching process by linking realistic synthetic electronic health records to clinical trial eligibility criteria using natural language processing methods.
View Article and Find Full Text PDFAlthough solvent additives are used to optimize device performance in many novel non-fullerene acceptor (NFA) organic solar cells (OSCs), the effect of processing additives on OSC structures and functionalities can be difficult to predict. Here, two polymer-NFA OSCs with highly sensitive device performance and morphology to the most prevalent solvent additive chloronaphthalene (CN) are presented. Devices with 1% CN additive are found to nearly double device efficiencies to 10%.
View Article and Find Full Text PDFACS Appl Mater Interfaces
December 2021
Commercialization and scale-up of organic solar cells (OSCs) using industrial solution printing require maintaining maximum performance at active-layer thicknesses >400 nm─a characteristic still not generally achieved in non-fullerene acceptor OSCs. NT812/PC71BM is a rare system, whose performance increases up to these thicknesses due to highly suppressed charge recombination relative to the classic Langevin model. The suppression in this system, however, uniquely depends on device processing, pointing toward the role of nanomorphology.
View Article and Find Full Text PDFAs organic photovoltaic performance approaches 20% efficiencies, causal structure-performance relationships must be established for devices to realize theoretical limits and become commercially competitive. Here, we reveal evidence of a causal relationship between mixed donor-acceptor interfaces and charge generation in polymer-fullerene solar cells. To do this, we combine a holistic loss analysis of device performance with quantitative synchrotron X-ray nanocharacterization to identify a >98% anticorrelation between field-dependent geminate recombination and nanodomain purity.
View Article and Find Full Text PDFBiallelic mutations in the SPATA5 gene, encoding ATPase family protein, are an important cause of newly recognized epileptic encephalopathy classified as epilepsy, hearing loss, and mental retardation syndrome (EHLMRS, OMIM: 616577). Herein we describe a family in which two SPATA5 mutations with established pathogenicity (p.Thr330del and c.
View Article and Find Full Text PDF